DrugPatentWatch Database Preview
Litigation Details for Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA Inc. (D. Del. 2014)
» See Plans and Pricing
Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA Inc. (D. Del. 2014)
| Docket | Start Trial | Date Filed | 2014-07-03 |
| Court | District Court, D. Delaware | Date Terminated | 2016-11-16 |
| Cause | 35:271 Patent Infringement | Assigned To | Sue Lewis Robinson |
| Jury Demand | None | Referred To | Sherry R. Fallon |
| Parties | APOTEX INC.; MERCK SHARP & DOHME CORP.; TEVA PHARMACEUTICALS USA INC. | ||
| Patents | 6,127,353 | ||
| Attorneys | Andrew E. Riley; Aviv Zalcenstein; Bindu Ann George Palapura; David Ellis Moore; David M. Hashmall; Derek James Fahnestock; Frederick H. Rein; Ira J. Levy; Jack B. Blumenfeld; John C. Phillips , Jr.; Joseph B. Crystal; Joshua A. Whitehill; Joshua P. Davis; Lindsay M. Volpenhein; Lisa M. Thomas; Michael B. Cottler; Michelle J. Eber; Nicolas G. Barzoukas; Richard L. Horwitz | ||
| Firms | Morris, Nichols, Arsht & Tunnell; Phillips, Goldman, McLaughlin & Hall, P.A. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA Inc.
The small molecule drug covered by the patent cited in this case is Start Trial .
Details for Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA Inc. (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-09-03 | 132 | alleging infringement of U.S. Patent No. 6, 127,353 ("the '353 patent") ("New Jersey/…henceforth will be to Civ. No. 14-874. to work on patent infringement litigation "relating to the drug…Merck failed to prove infringement of the '353 patent and dismissed Merck's claims. (Id., ex. 7A)…July 2014, asserting infringement of the '353 patent. Merck instituted Civ. No. 15-250 against defendant…March 2015, asserting infringement of the '353 patent. Also in March 2015, Merck instituted a second | External link to document | |
| 2015-09-03 | 133 | disputed claim language of U.S. Patent No. 6,127,353 ("the '353 patent") shall be construed…quot;Mometasone furoate monohydrate." The patented invention "relates to the novel compound… 16 November 2016 1:14-cv-00874 830 Patent None District Court, D. Delaware | External link to document | |
| 2015-11-24 | 149 | Victor Young Regarding Infringement of U.S. Patent No. 6,127,353 filed by Merck Sharp & Dohme Corp..(Fahnestock… 16 November 2016 1:14-cv-00874 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
